Cornelissen 2019, ERα over-expression does not accelerate development of p53-deficient mammary tumors in mice.

Description

Genome binding profiling by high throughput sequencing of exogenously introduced mouse and human ERα in an existing p53-deficiency driven breast cancer mouse model.

Source

Samples

From M. musculus (July 2007 NCBI37/mm9).

ChIP-seq data:

Filename Description Feature GEO-ID
1 GSM3640241.sga MMECs GEM|Input-HA||rep1 Input-HA GSM3640241
2 GSM3640242.sga MMECs GEM|Input-HA||rep2 Input-HA GSM3640242
3 GSM3640243.sga MMECs GEM|ESR1-HA||rep1 ESR1-HA GSM3640243
4 GSM3640244.sga MMECs GEM|ESR1-HA||rep2 ESR1-HA GSM3640244
5 GSM3640245.sga MMECs GEM|Esr1-HA||rep1 Esr1-HA GSM3640245
6 GSM3640246.sga MMECs GEM|Esr1-HA||rep2 Esr1-HA GSM3640246

Notes on samples nomenclature:

MMECs GEM stands for genetically engineered mouse mammary epithelial cells.

Technical Notes

FASTQ files were extracted from SRA files using fastq-dump (SRA toolkit v2.5.0) and mapped to the genome using Bowtie v1.2.2. SAM files were then converted to BAM using samtools v1.9 and to BED using bamToBed v2.27.0 (bedtools). BED to SGA conversion was carried out using bed2sga (ChIP-Seq v. 1.5.5).

References

Last update: 22 Apr 2020